Fluor Corporation (FLR)
Return on equity (ROE)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 2,145,000 | 260,000 | 412,000 | 304,000 | 115,000 | -73,000 | -249,000 | -244,000 | -66,000 | -135,169 | -124,700 | -197,368 | -332,392 | -216,661 | -523,089 | -683,367 | -862,302 | -865,810 | -1,341,835 | -1,729,697 |
| Total stockholders’ equity | US$ in thousands | 3,949,000 | 2,251,000 | 2,142,000 | 1,951,000 | 1,940,000 | 1,883,000 | 1,797,000 | 1,719,000 | 1,786,000 | 1,650,000 | 1,514,000 | 1,469,000 | 1,392,450 | 1,597,530 | 1,515,550 | 983,654 | 1,030,250 | 1,091,640 | 1,487,750 | 1,091,640 |
| ROE | 54.32% | 11.55% | 19.23% | 15.58% | 5.93% | -3.88% | -13.86% | -14.19% | -3.70% | -8.19% | -8.24% | -13.44% | -23.87% | -13.56% | -34.51% | -69.47% | -83.70% | -79.31% | -90.19% | -158.45% |
December 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $2,145,000K ÷ $3,949,000K
= 54.32%
Fluor Corporation's return on equity (ROE) has shown a significant improvement over the past few quarters. The ROE was negative in the range of -158.45% to -79.31% from March 2020 to September 2020, indicating that the company was not generating sufficient profits to cover shareholder investments during this period.
However, there was a gradual improvement in the ROE from December 2020 onwards, with the percentage moving towards positive territory. The ROE improved to 54.32% by December 2024, indicating that the company's profitability relative to equity has strengthened significantly.
Overall, the trend in Fluor Corporation's ROE suggests that the company has been able to enhance its profitability and efficiency in generating returns for shareholders over the evaluated period. It is essential for investors and stakeholders to monitor this metric to assess the company's performance and financial health accurately.
Peer comparison
Dec 31, 2024